Trials / Completed
CompletedNCT04531904
Prospective Evaluation to Characterize the Real-World Performance of the EMBOVAC Aspiration Catheter
Prospective Evaluation to Characterize the Real-World Performance of the EMBOVAC Aspiration Catheter for Neurothrombectomy: A Post-Market Clinical Follow-up Trial.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 102 (actual)
- Sponsor
- Cerenovus, Part of DePuy Synthes Products, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A post-market study evaluating the EMBOVAC Aspiration Catheter in acute ischemic stroke patients with confirmed intracranial large vessel occlusion.
Detailed description
The PERFECT Study is a prospective, multi-center, single arm, post-market clinical follow-up study. The objective of this post-market clinical follow-up study is to assess the performance of the EMBOVAC Aspiration Catheter in the treatment of acute ischemic stroke in a real-world clinical setting. The study will also report on clot characteristics and clinical outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | EMBOVAC Aspiration Catheter | The EMBOVAC Aspiration catheter is used to treat acute ischemic stroke. The catheter can be used to facilitate introduction of diagnostic or therapeutic agents and is also intended for use in removal/aspiration of emboli and thrombi from selected blood vessels in the neuro vasculature. |
Timeline
- Start date
- 2020-10-15
- Primary completion
- 2022-05-02
- Completion
- 2022-07-26
- First posted
- 2020-08-31
- Last updated
- 2024-01-26
- Results posted
- 2024-01-26
Locations
2 sites across 2 countries: Germany, United Kingdom
Source: ClinicalTrials.gov record NCT04531904. Inclusion in this directory is not an endorsement.